Global Endometrial Cancer Therapeutics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023 – Market Research Report 2017

OrbisResearch.com has published new research report on "Global Endometrial Cancer Therapeutics Market Research Report and Forecast to 2017-2023" to its database.

Dallas, United States - July 17, 2017 /MarketersMedia/ —

Endometrial Carcinoma is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, endometrial cancer is also the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of uterus were estimated to be diagnosed during 2016, and about 10,470 women died from cancers of the uterine body during the same year.Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial Cancer can be treated by one or combination of therapies, such as chemotherapy, radiation therapy, hormone therapy, and surgery. Most of the physicians generally recommend combination treatments because chemotherapy alone has conventionally been deemed ineffective. Furthermore, adjuvant radiation therapy is ideal in patients who have diagnosed with Stage I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer.

Browse the report: http://www.orbisresearch.com/reports/index/global-endometrial-cancer-therapeutics-market-by-therapy-chemotherapy-hormone-therapy-radiation-therapy-surgery-by-enduser-research-institutes-hospitals-and-clinics-and-pipeline-analysis-outlook-to-2023

According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised to reach approximately US$ 27 Billion by 2023. In this report, there is in-depthmarket analysis as well as market segmentation of global endometrial cancer therapeutics. The market potential of endometrial cancer therapeutic drugsisestimated considering that these are being tested in clinical trials for endometrial cancer, besides the ones which have already been approved. The depictedendometrial cancer therapeutic drugsare expected to show their complete market potential soon in the coming years.

Furthermore, in this report we have structured the information on epidemiology of endometrial cancer in the world. The report also covers pipeline analysis of endometrial cancer therapeutic drugs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. Moreover, our report places an emphasis on the major drivers and challenges, latest trends and developments,as well as strategic collaborations that can impact industry’s growth.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/333581

In the end, the report enlists some of the key players in the Endometrial Cancer Therapeutics market including business overview of each player along with their product and pipeline portfolios, recent developments, and comparative analysis of their strengths and weaknesses.Conclusively, the report will prove to be a complete and comprehensive source of knowledge and analysis for clients and potential investors or debut makers in this industry.

Major Points From The Table Of Contents:
Analyst View
Research Methodology
Endometrial Cancer - Epidemiology & Risk Factors
Endometrial Cancer Therapeutics - An Introduction
Market Dynamics
Endometrial Cancer Therapeutics Market Outlook to 2023
Market Segmentation
Endometrial Cancer Therapeutic Drugs Pipeline Analysis
Trends and Developments
Strategic Mergers & Collaborations in the Endometrial Cancer Therapeutics Industry
Competitive Assessment

Buy the report@http://www.orbisresearch.com/contact/purchase/333581

List of Figures:
Figure 3-1: Estimated Age-specific Incidence & Mortality Rates for Endometrial Cancer, 2016
Figure 4-1: Endometrial Cancer Therapeutic Drugs - Mechanism of Action
Figure 5-1: Global Healthcare Spending (Billion US$), 2015 & 2020
Figure 5-2: Healthcare Spending by Region (Billion US$), 2015 & 2020
Figure 6-1: Global - Endometrial Cancer Therapeutics Market (Billion US$), 2016-2023
Figure 7-1: Global - Endometrial Cancer Therapeutics Market by Therapy (%), 2016
Figure 7-2: Global - Endometrial Cancer Chemotherapy Market (Billion US$), 2016 & 2023
Figure 7-3: Global - Endometrial Cancer Hormone Therapy Market (Billion US$), 2016 & 2023
Figure 7-4: Global - Endometrial Cancer Radiation Therapy Market (Billion US$), 2016 & 2023
Figure 7-5: Global - Endometrial Cancer Surgery Market (Billion US$), 2016 & 2023
Figure 7-6: Global - Endometrial Cancer Therapeutics Market by End Users (%), 2016
Figure 7-7: Global - Endometrial Cancer Therapeutics Market by Research Institutes (Billion US$), 2016 & 2023
Figure 7-8: Global - Endometrial Cancer Therapeutics Market by Hospitals (Billion US$), 2016 & 2023

List of Tables:
Table 6-1: Potential Patients for Endometrial Cancer Therapeutics, 2015, 2020 & 2025
Table 8-1: Industrial Endometrial Cancer Therapeutic Drugs Pipeline
Table 8-2: Research Collaborations Endometrial Cancer Therapeutic Drugs Pipeline
Table 10-1: Strategic Mergers & Collaborations in Endometrial Cancer Therapeutics Industry, 2014-2016
Table 11-1: Top Companies by Endometrial Cancer Therapeutic Drugs in Pipeline (2016)
Table 11-2: Bayer AG - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-3: Bayer AG - Key Financials (Million US$), 2014-2016
Table 11-4: F. Hoffman La Roche Ltd. - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-5: F. Hoffman La Roche Ltd. - Key Financials (Million US$), 2014-2016

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: sales@orbisresearch.com
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: http://marketersmedia.com/global-endometrial-cancer-therapeutics-market-projections-swot-analysis-risk-analysis-trends-and-forecast-by-2023-market-research-report-2017/217971

For more information, please visit http://www.orbisresearch.com/reports/index/global-endometrial-cancer-therapeutics-market-by-therapy-chemotherapy-hormone-therapy-radiation-therapy-surgery-by-enduser-research-institutes-hospitals-and-clinics-and-pipeline-analysis-outlook-to-2023

Source: MarketersMedia

Release ID: 217971

Latest News

The Latest: UN chief condemns attack on Afghan vote center

Apr 24, 2018

KABUL, Afghanistan — The Latest on the violence in Afghanistan (all times local): 6 a.m. U.N. Secretary-General Antonio Guterres has condemned the attack on a voter registration center in Afghanistan. The suicide bombing in Kabul on Sunday killed at least 57 people with more than 100 wounded. The Islamic State group claimed responsibility, saying it targeted Shiite "apostates." Guterres said the culprits must be brought to justice. "They must not be allowed to succeed in deterring Afghan citizens from carrying out their constitutional right to take part in forthcoming elections." He extended condolences to the families and expressed solidarity with...

Nepal honors 1st conquest of Everest without bottled oxygen

Apr 24, 2018

KATHMANDU, Nepal — Nepal's government on Thursday honored two climbers who were the first to scale Mount Everest without supplementary oxygen 40 years ago. Minister for Tourism Rabindra Adhikari praised the climbers at a ceremony in the capital, Kathmandu. Italian Reinhold Messner and Austrian Peter Habeler reached the summit without use of supplementary oxygen, while others on their team used bottled oxygen. Until then, all climbers carried oxygen cylinders to aid them at high altitudes where oxygen levels are low. Since Everest was first scaled in 1953, thousands of climbers have reached the summit and hundreds more make attempts every...

Iran bans government bodies from using foreign message apps

Apr 24, 2018

TEHRAN, Iran — Iran's presidency has banned all government bodies from using foreign-based messaging apps to communicate with citizens, state media reported Wednesday, after economic protests organized through such apps shook the country earlier this year. Chief among those apps is Telegram, used by over 40 million Iranians for everything from benign conversations to commerce and political campaigning. Iranians using Telegram, which describes itself as an encrypted message service, helped spread the word about the protests in December and January. Telegram channels run on behalf of Iran's Supreme Leader, Ayatollah Ali Khamenei, and Vice President Eshaq Jahangiri were already shut...

Sherpa guide trying to reach top of the world for 22nd time

Apr 24, 2018

KATHMANDU, Nepal — Three men have climbed to the top of the world 21 times, all of them mountain guides who grew up in the shadow of Mount Everest. Two of these famed Sherpa guides have retired. But 48-year-old Kami Rita says he'll be summiting Everest for years to come. "My goal is to reach the summit of Everest at least 25 times," he told The Associated Press in Kathmandu, Nepal's capital, shortly before heading back to the mountain for what he hopes will mark a record-breaking climb. "I want to set a new record not just for myself but...

23 children die in India when school bus plunges into gorge

Apr 24, 2018

NURPUR, India — A school bus plunged off a mountain road Monday into a deep gorge in the Himalayan foothills, killing 23 children, some as young as 4, Indian officials said. Four adults also died, said Sandeep Kumar, a local official. Ten children were hospitalized. Initial reports indicated the bus driver was speeding as he took the children home and lost control at the edge of the gorge. The bus fell some 200 feet (60 meters) to the ground below, said police officer Sunil Kumar. The adults killed included the bus driver, two teachers and another woman, officials said. Most...

Search
Broaden News

Sign up now!

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us: sales[at]recentdiscovery.com